Pediatric disease burden and vaccination recommendations : understanding local differences

dc.contributor.authorGentile, Angela
dc.contributor.authorBhutta, Zulfiqar
dc.contributor.authorBravo, Lulu
dc.contributor.authorSamy, Aly Gamal
dc.contributor.authorGarcia, R. Dennis J.
dc.contributor.authorHoosen, Anwar Ahmed
dc.contributor.authorIslam, Tazul
dc.contributor.authorKarimi, Abdollah
dc.contributor.authorSalem, Mona
dc.contributor.authorSimasathien, Sriluck
dc.contributor.authorSohail, Amir
dc.contributor.authorWatanaveeradej, Veerachai
dc.contributor.authorWiedenmayer, Karin
dc.contributor.authorSchmitt, Heinz-J.
dc.date.accessioned2010-06-04T11:45:56Z
dc.date.available2010-06-04T11:45:56Z
dc.date.issued2010
dc.description.abstractBACKGROUND: Diphtheria (D), tetanus (T), pertussis (P), hepatitis B (HepB), invasive Haemophilus influenzae type b (Hib) disease, and measles cause substantial global morbidity and mortality. METHODS: This unique review highlights geographic differences in disease burden across certain countries in the African, Americas, Mediterranean, South-East Asian, and Western Pacific World Health Organization (WHO) regions, and relates this to vaccination coverage and local vaccine recommendations using the authors’ countries as illustrations. RESULTS: Substantial differences were observed in the incidence of these diseases and in vaccination coverage between the countries studied. Disease incidence often reflected inadequate surveillance, but also variable or poor vaccination coverage. Vaccination coverage against HepB was particularly low in the African and South-East Asian WHO regions; vaccination coverage against invasive Hib disease was low in these regions and in the Eastern Mediterranean and Western Pacific WHO regions. Vaccination schedules within some countries in these regions do not include, or have only recently included, vaccinations against HepB and Hib disease. The use of DTwP–HepB–Hib (diphtheria, tetanus, whole-cell pertussis, HepB, Hib) combination vaccines has now been adopted by some countries to help increase vaccination coverage. CONCLUSIONS: Vaccination coverage and vaccination schedules vary markedly between the countries studied, often according to the resources available. DTwP–HepB–Hib combination vaccines represent a cost-effective option, with the potential to substantially reduce the burden associated with these diseases by increasing coverage and compliance.en_US
dc.identifier.citationGentile A, et al. Pediatric disease burden and vaccination recommendations: understanding local differences. Int J Infect Dis (2010), doi:10.1016/j.ijid.2009.11.006en_US
dc.identifier.issn1201-9712
dc.identifier.other10.1016/j.ijid.2009.11.006
dc.identifier.urihttp://hdl.handle.net/2263/14211
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rightsElsevieren_US
dc.subjectPertussisen_US
dc.subjectDiphtheriaen_US
dc.subjectTetanusen_US
dc.subjectHepatitis Ben_US
dc.subjectHaemophilus influenzae type ben_US
dc.subjectMeaslesen_US
dc.titlePediatric disease burden and vaccination recommendations : understanding local differencesen_US
dc.typePostprint Articleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Gentile_Pediatric(2010).pdf
Size:
426.32 KB
Format:
Adobe Portable Document Format
Description:
Postprint Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.43 KB
Format:
Item-specific license agreed upon to submission
Description: